Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity

Eliciting effective antitumor immune responses in patients who fail checkpoint inhibitor therapy is a critical challenge in cancer immunotherapy, and in such patients, tumor-associated myeloid cells and macrophages (TAMs) are promising therapeutic targets. We demonstrate in an autochthonous, poorly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Med
Main Authors: Perry, Curtis J., Muñoz-Rojas, Andrés R., Meeth, Katrina M., Kellman, Laura N., Amezquita, Robert A., Thakral, Durga, Du, Victor Y., Wang, Jake Xiao, Damsky, William, Kuhlmann, Alexandra L., Sher, Joel W., Bosenberg, Marcus, Miller-Jensen, Kathryn, Kaech, Susan M.
Formato: Artigo
Idioma:Inglês
Publicado em: Rockefeller University Press 2018
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5839759/
https://ncbi.nlm.nih.gov/pubmed/29436395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20171435
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados